Newsroom

JANUARY 2021 Kayla Hui, MPH Trying to stay healthy after contracting COVID-19 is one hurdle, but managing it with a chronic disease can be especially challenging. Based on what is known about COVID-19, adults living with an underlying medical condition are at heightened risk for severe illness, especially people living with diabetes.1 As a result, experts are emphasizing people with diabetes...

JANUARY 2021 Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec The COVID-19 pandemic continues to put an unprecedented amount of strain on the entire healthcare sector, and the industry has responded by accelerating the ways innovation is developed and adopted. Health leaders have faced a generational challenge and the result has been the rapid deployment of...

JANUARY 2021 Quinn Phillips For months now, it’s been clear that diabetes is a major risk factor for worse outcomes in people who develop COVID-19. Study after study has shown that people with diabetes are more likely to be hospitalized with the viral illness, and to experience worse outcomes — including a higher risk of death — if they are hospitalized with the disease. But it’s not all doom...

DECEMBER 2020 LabMedica International staff writers Diabetes and hyperglycemia have emerged as important risk factors for hospitalization, disease severity, acute kidney injury, acute respiratory distress syndrome, intensive care unit (ICU) admissions, and death in patients with coronavirus disease 2019 (COVID-19). Hypoglycemia, also called low blood glucose or low blood sugar, occurs when the...

NOVEMBER 2020 Koren Thomas Diabetes nurses work on the frontlines in the fight against an ongoing epidemic/pandemic that will continue to afflict over 13% of the US population long after COVID-19 recedes into the background. The diabetes pandemic has been mounting rapidly in the early 21st century. In 2003, 194 million adults worldwide between the ages of 20 and 79 had diabetes. By 2025, it is...

NOVEMBER 2020 DR. JORDAN MESSLER, MD, SFHM, FACP More than seven million COVID-19 cases have been recorded in the United States, with over 400,000 of those individuals requiring hospitalization. Unfortunately, it’s safe to assume another spike in cases and hospitalizations are forthcoming this winter, with many states already seeing an increase. To better treat COVID-19 patients today and...

OCTOBER 2020 First study to utilize CGM data with FDA-cleared, cloud-based titration software suggests significantly improved outcomes for patients while optimizing clinical resources This past summer, Glytec published the first proof-of-concept study that combines FDA-cleared remote insulin titration software and data from continuous glucose monitoring (CGM) systems. Results of the study,...

SEPTEMBER 2020 DR. JORDAN MESSLER, MD, SFHM, FACP Glucometrics – the system-wide analysis of inpatient glucose data – should be of fundamental interest for hospital administrators striving to improve the outcomes of their patients. Why is this data so important? Proper glycemic control has been linked to improved outcomes and decreased length of stay time and time again across a myriad of...

SEPTEMBER 2020 KEITH LORIA The work of moving away from fee for service is in progress. The results so far? Mixed. Will COVID-19 accelerate or put the brakes on the move toward value-based payment? Christopher Chen, M.D., CEO of Miami-based ChenMed, says doctors will embrace value over volume as layoffs and work reductions hit hospitals and medical practices that depend on fee for service....

Collaboration Seeks to Improve Outcomes and Reduce Cost of Care for the 25% of Veterans with Diabetes WALTHAM, MASS. (July 7, 2020) – Glytec, the only provider of insulin management software across the continuum of care, and ThunderCat Technology, a Service-Disabled Veteran-Owned Small Business (SDVOSB) that delivers technology products and services to government organizations, today announced a...